Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

Pancreatic Cancer Serum and Peripheral Blood Lymphocyte Repository

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00898482

Enrollment

Registered

2009-05-12

Start date

2005-05-31

Completion date

2011-06-30

Last updated

2015-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Keywords

adenocarcinoma of the pancreas, recurrent pancreatic cancer, stage I pancreatic cancer, stage II pancreatic cancer, stage III pancreatic cancer, stage IV pancreatic cancer

Brief summary

RATIONALE: Collecting and storing samples of blood from patients with cancer and healthy participants to test in the laboratory may help the study of cancer in the future. PURPOSE: This study is collecting and storing samples of blood from patients with pancreatic cancer and healthy participants.

Detailed description

OBJECTIVES: * Establish a central pancreatic cancer specimen (including serum and peripheral blood lymphocytes) repository to serve as a resource for current or future scientific studies. * Utilize the clinical database to perform clinicopathologic correlation with the results of those studies. * Test new hypotheses as they emerge. OUTLINE: This is a prospective study. Blood is collected from patients with pancreatic cancer at baseline and then every 3-6 months for up to 2 years. All other participants have blood collected at baseline and complete questionnaires at baseline and then every 3-6 months for up to 2 years. Serum and peripheral blood lymphocytes obtained from the blood samples are frozen and stored. PROJECTED ACCRUAL: A total of 200 patients and 200 other participants will be accrued for this study.

Interventions

OTHERThis is a non-intervention study for all groups.

This is a non-intervention study.

OTHERstudy of socioeconomic and demographic variables

Non-intervention study.

Study design

Observational model

CASE_ONLY

Eligibility

Sex/Gender

ALL

Age

18 Years to 120 Years

Healthy volunteers

Yes

Inclusion criteria

DISEASE CHARACTERISTICS: * Meets 1 of the following criteria: * Histologically confirmed pancreatic malignant neoplasm * Serologically or image-confirmed diagnosis of pancreatitis or nonmalignant pancreatic disease * Healthy, at-risk participant meeting the following criteria: * Smoker, diabetic, and/or has a family history of pancreatic cancer * Healthy participant (no history of cancer) PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Design outcomes

Primary

Measure	Time frame
Establishment of a central pancreatic cancer specimen repository	No time frame
Utilization of the clinical database to perform clinicopathologic correlation with the results of current or future scientific studies	No time frame
Test new hypotheses as they emerge	No time frame

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026